Clinical Trial Update: Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin as adjuvant therapy in patients with ulcerative colitis and inflammatory bowel diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: National Hepatology & Tropical Medicine Research Institute | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Status: UNKNOWN